When we think of human papillomavirus (HPV), the first association that comes to mind is cervical cancer. That link is well established. But what most people don’t realise is that HPV has now quietly become the leading cause of a completely different and rapidly rising cancer—oropharyngeal cancer—particularly in men. These cancers, which fall under the broader umbrella of head and neck cancers, often strike parts like the tonsils and the base of the tongue.
On World Head and Neck Cancer Day, experts are ringing the alarm bells: it’s time we start talking about HPV in men with the same urgency that we do for women.
More Men, More Risk
According to a 2023 study published in The Lancet Oncology, HPV-related oropharyngeal cancers are now five times more common in men than women. “This isn’t just a medical statistic; it’s a warning signal,” says Dr. Akash Tiwari, Consultant, Oral and Maxillofacial Surgical Oncology. “We’re seeing a sharp increase in these cases, particularly in high-income countries, and the common link is persistent high-risk HPV infection.”
What’s making men so vulnerable? For starters, transmission. Oral HPV is most commonly passed during intimate skin-to-skin contact, especially through oral sex. Although most HPV infections clear up on their own, some high-risk strains like HPV-16 can hang around silently in the tissues of the throat and, over time, turn cancerous.
Why Men Struggle to Fight It Off
“Biologically, men are more likely to contract oral HPV and less likely to clear the infection,” explains Dr. Aarzoo Saliya, Consultant ENT, Head and Neck Onco Surgeon. “It may come down to immune differences, sexual behaviour patterns, or even lack of awareness.”
Unlike many infections that cause noticeable symptoms, oral HPV is sneaky. It often produces no signs, which means people can be completely unaware they’re carrying it or, worse, passing it on. And when symptoms do show up, they’re usually vague, making early diagnosis tough.
Symptoms You Should Watch For
HPV-related oropharyngeal cancer doesn’t always scream for attention. But if you’ve had any of these signs persistently, it might be time to get checked:
“These aren’t symptoms people usually rush to a doctor for,” says Dr. Tiwari. “But in the context of HPV-related oropharyngeal cancer, they’re red flags.” Unlike traditional tobacco- or alcohol-related oral cancers, HPV-related cases often don’t present with obvious visible lesions, which adds to the challenge.
Prevention Starts Early
The good news is that we can prevent it. The same HPV vaccine that’s widely recommended for cervical cancer prevention in girls works just as well to prevent the strains of HPV that cause oropharyngeal cancer.
“The most effective way to reduce risk is through timely vaccination,” says Dr. Saliya. “Ideally, the vaccine should be given before someone becomes sexually active; that’s why it’s recommended at ages 11 or 12 but can still be taken up to age 26 if missed earlier.”
Yet, in many places, the uptake of the HPV vaccine among boys remains painfully low, mostly because the risk in men hasn’t received the same attention.
Changing the Conversation Around HPV
There’s also a major need to shift public perception. “HPV isn’t just a ‘women’s issue’, and it certainly isn’t just about cervical cancer,” Dr. Tiwari stresses. “It’s a sexually transmitted virus that can affect everyone, and the consequences for men are becoming increasingly clear.”
That means raising awareness around safe sexual practices, routine screenings for those at risk, and greater openness about male HPV-related health risks. Men, particularly young adults, need to be part of the vaccination narrative.
Know the Risks, Take Action
On a day that spotlights head and neck cancers globally, the message is simple but urgent: HPV-related oropharyngeal cancer in men is real, rising, and largely preventable. Ignoring it isn’t just unwise; it’s dangerous. Whether you’re a parent considering the HPV vaccine for your son, a man experiencing persistent symptoms, or someone simply unaware of how far-reaching HPV’s impact can be, now’s the time to pay attention. Early action, education and vaccination can quite literally save lives.
Credits: Canva
Sepsis that happened by a lick from a pet dog led to a woman losing all four of her limbs. Health and Me had previously reported that a Birmingham based woman, 56-year-old pharmacy worker Manjit Sangha caught sepsis from the lick of her pet dog. She spent her night in coma in the hospital and had to lose all her limbs. This happened because bacteria from dog's lick entered her body through a cut or a scratch. This led to sepsis, where the immune system's reaction to infection damaged the body's own tissues and organs.
This has brought a lot of attention on what sepsis is and what are the symptoms one must be aware of. As per the Sepsis Alliance, one must know about TIME to be aware of sepsis.
TIME stands for temperature, infection, mental decline and extremely ill. If you notice these symptoms, rush to the hospital.
Your body temperature normally stays steady at about 98.6°F (37°C), with small changes based on activity, surroundings, and time of day. A reading of 100°F (37.7°C) or higher is considered a fever. During infection, the body often heats up to help fight germs. However, some people experience an unusual drop in temperature instead. Because of this, both a spike and a fall in temperature can be warning signs of sepsis.
When an infection stays in one area, its symptoms usually match the site involved. A urinary tract infection may cause burning while urinating or frequent urges, pneumonia can bring cough and chest pain, and an infected cut may show redness or pus.
If the infection spreads through the body, broader symptoms like fever, tiredness, and body aches can appear. In some cases, an infection may not cause obvious symptoms at all. This is especially important to remember after surgery, medical procedures, skin injuries, or close contact with someone who is sick.
Sepsis can also alter how the brain functions. Some people, particularly older adults, may not develop the usual infection symptoms. Instead, they might suddenly become confused or show a sharp worsening of existing dementia. Marked drowsiness or unusual sleepiness is another common sign.
Many sepsis survivors recall feeling sicker than ever before. They describe overwhelming symptoms such as the most severe sore throat or abdominal pain they had experienced, along with a frightening sense that they might not survive.
| A Child Who | Child under 5 (Infant) Who |
| Feels abnormally cold to touch | Is not eating |
| Looks mottled, bluish or has very pale skin | Is vomiting repeatedly |
| Has a rash that does not fade when you press it | Has not urinated in 12 hours |
| Is breathing very fast | |
| Has a convulsion | |
| Is very lethargic or is facing difficulty in waking up |
Credits: SWNS (Tianna Moon)
Mounjaro, a popular weight loss drug that helped many lose weight, however, in this one case, a woman, who was on the same drug noticed something different. While she lost weight, she noticed that her breasts continued to grow. The 30-year-old Tianna Moon of East Anglia, a region in eastern England first realized something was not normal with her chest in 2024. This was when she started to use Mounjaro.
She was losing weight, but her breasts continued to grow. This is when Moon's doctor diagnosed her with a rare disease call gigantomastia, which causes breast tissue to grow rapidly and in excess.
Also Read: 15 States Sue Trump Administration Over Revised Vaccine Schedule
Moon said that the doctors had thought that she had macromastia, a less severe, however, a similar condition. "But when I broke down medical history, the weight loss on Mounjaro and the increased growth and side effects, he was point-blank like, 'This is gigantomastia'," she said.
Moon also told that her breasts currently weight 39 lbs, which is approximately 20 per cent of her overall body weight.
Moon also said that while her large breasts are "normal" at this point in her life, she said the rare condition still comes with challenges.
"The side effects are having numb arms quite a lot and having quite severe indentations on my shoulders. I have some light scarring under my breasts where bras have rubbed and ripped the skin open."
She also said that laying on her back is something she cannot do for a long time, as it restricts the amount of airflow she can get in. She also said that when she goes out she tries to make her breasts look smaller than they are and strap them up. "I [still] get stares and double takes."
Also Read: Wegovy And Ozempic Will Cost Less In 2027, Novo Nordisk Slashes Weight Loss Drugs Prices By Half
As per Cleveland Clinic, it is a rare condition where your breasts become excessively large. It can also cause pain, infection, discomfort and issues with body image. It is also known as breast hypertrophy where one experiences rapid and disproportionate breast growth. The speed with which the breasts grow could vary depending on the person. It could take a few weeks to over several years. The tissue is almost never benign.
Moon is now considering a breast reduction surgery. She has for now set up an account on OnlyFans. “I might as well try and reap the benefits of my medical condition rather than the negatives," she said.
Credit: X
The recent launch of the indigenous Td vaccine in India by Union Health Minister JP Nadda will boost immunity and reduce the risk of tetanus and diphtheria in children and adults, said health experts.
Union Health Minister JP Nadda formally launched the indigenously manufactured Td vaccine in Himachal Pradesh last week.
With the launch, the Tetanus Toxoid (TT) vaccine has been replaced with the Tetanus and adult diphtheria (Td) vaccine in India’s immunization program for all age groups, including pregnant women.
The move comes amid increasing numbers of cases of diphtheria amongst older age groups. Tetanus and diphtheria can lead to hospitalizations or even cause death. The Td vaccine will help to decrease diphtheria outbreaks.
“In keeping with global practice, India has shifted from TT, which covers for tetanus, to Td, which covers for both tetanus and diphtheria. This vaccine is indigenously manufactured and is expected to significantly reduce the risk of both these diseases in older children as well as adults,” Dr. Rajeev Jayadevan, Ex-President of IMA Cochin and Convener of the Research Cell, Kerala, told HealthandMe.
The Td vaccine, indigenously manufactured at the Central Research Institute (CRI), Kasauli in Himachal Pradesh, is a combination of tetanus and diphtheria with a lower concentration of diphtheria antigen (d), and is recommended for older children and adults.
The use of Td, instead of TT, is recommended during pregnancy to protect against maternal and neonatal tetanus and diphtheria during prenatal care.
Vaccination during pregnancy also serves to boost immunity and increase the duration of protection in pregnant women who have not received the full set of recommended booster doses.
The Td is a safe vaccine, and 133 countries are currently using it.
The Health Ministry, in a statement, said that the Central Research Institute will supply 55 lakh doses to the UIP by April 2026, with production expected to scale up progressively in subsequent years to further strengthen the Universal Immunization Program in India.
“India’s indigenous Td vaccine rollout marks a significant milestone in strengthening the nation’s immunization program by enhancing self-reliance, affordability, and supply stability,” Dr. Neha Rastogi, Senior Consultant - Infectious Diseases, Fortis Gurugram, told HealthandMe.
“Locally produced vaccines reduce dependency on imports, ensuring uninterrupted protection for adolescents and adults against tetanus and diphtheria. This initiative supports wider coverage, faster distribution to remote regions, and improved public health preparedness,” she added.
As per the National Health Profile 2022, India has reported 1,586 cases and 22 deaths due to diphtheria in 2020, and 3,677 cases and 47 deaths in 2021.
Around 10 Indian states report the majority (84 per cent) of the cases.
As of 21 June 2024, Orissa has also reported six deaths and 21 suspected diphtheria cases. There has been more than 90 percent coverage of diphtheria vaccination in birth cohorts since 2014, but gaps in booster dose coverage are widely prevalent.
Plugging of gaps in the routine immunization, coupled with inclusion of booster doses in the national data on diphtheria vaccination, is the need of the hour.
“Diphtheria is one of the most dangerous infectious diseases known to man; it spreads easily through the respiratory route. It can cause death due to the bacterial toxin affecting the heart (Myocarditis). It is vaccine-preventable, but the immunity fades over time,” Dr. Jayadevan said.
Therefore, the Td booster shots at ages 10 and 16 are essential to maintain protection. Similarly, pregnant women should receive two doses to protect both mother and child.
Given the recent outbreaks of diphtheria in India and elsewhere, this transition is a public health priority, the expert said.
© 2024 Bennett, Coleman & Company Limited